Ann: SDV 2025 Annual Report, page-2

SciDev Ltd (ASX: SDV) (“SciDev” or “the Company”) today announces its financial and operational
results for the twelve months ended 30 June 2025 (FY25).
In FY25, SciDev delivered solid strategic progress, growing its client footprint and expanding the
reach of its flagship technologies. Revenue of $103.4 million was slightly down on the prior year,
reflecting a continued move away from commodity chemistry sales and delays in the
commencement of new contracts in the domestic Water business. Gross Profit improved slightly
YOY to 28%. Underlying EBITDA of $7.1 million was marginally lower than FY24 and reflected
increased investment in initiatives for growth. The business maintained positive operating cash
flow and closed the year with $9.7 million in cash.
The year finished strongly, with more than $21 million in new contracts secured in the fourth
quarter. In US Oil & Gas, focused business development in the Permian Basin gained real traction,
with CatChek™ proving its unique value proposition and delivering year-on-year sales growth of
more than 46%. PFAS remediation also advanced materially in FY25, as global markets began to
shift from investigation to action. SciDev’s best-in-class solutions gained significant traction in
the US and Europe, highlighted by the execution of our first commercial contracts for PFAS
treatment in both regions.
The Company continued to evaluate strategically aligned growth opportunities, including a
potential acquisition that was ultimately abandoned when it no longer aligned with the best
interests of our shareholders. This reflects SciDev’s disciplined approach to capital allocation and
focus on creating long-term shareholder value.
 FY26 expected revenue range of $120–140m.